Klaus von Lindeiner-Wildau

Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada.

Bayerische Landesbank engages in the provision of commercial banking and financial services. It offers products in the areas of export and trade finance, documentary business, interest and currency management, derivatives, payment services, and leasing for middle-market companies. The company was founded on June 27, 1972 and is headquartered in Munich, Germany.

Wacker Chemie founded in 1914 by Dr. Alexander Wacker. It is globally operating chemical company headquartered in Munich, Germany. Its portfolio focuses on semiconductor technology, silicone chemistry and specialty chemicals. It works at 22 production sites in Europe, the Americas and Asia, and over 100 sales offices around the globe.

Part of Searchlight Pharma, Inc., Nuvo Research AG is a Swiss pharmaceutical manufacturing company. The company is based in Fribourg, Switzerland.

Power Paper Ltd. develops and manufactures printed energy cells. It specializes in the design, creation, and licensing of printable batteries. The company was founded by Zvi Nitzan and Barush Levanon in 1997 and is headquartered in Beit Shemesh, Israel.